Transcatheter aortic valve implantation (TAVI) has become an established treatment for symptomatic aortic valve stenosis in inoperable patients and high-risk patients. In Germany the TAVI procedure has now surpassed the annual numbers of isolated surgical aortic valve replacement with a recent trend towards treatment of intermediate-risk patients; however, before TAVI can also be used in patients with lower surgical risk, studies are required to demonstrate the safety and efficacy of this method for this patient population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00059-016-4406-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!